Global infusion devices market to reach $23.08 billion by 2031, driven by rising healthcare demands

From GlobeNewswire: 2025-01-24 05:00:00

The global infusion devices market is projected to reach US$ 23.08 billion by 2031, with a CAGR of 6.7% from 2023. Key players focus on strategic developments to ease treatment of chronic disorders like diabetes and cancer. North America led the market in 2023, with Asia Pacific expected to show the highest CAGR.

The rising prevalence of cancer worldwide is driving demand for infusion devices used in therapies like chemotherapy, immunotherapy, and targeted therapy. Major market players are launching advanced products to enhance treatment efficacy and safety. The global incidence of cancer is expected to reach 32.6 million by 2045, creating a significant burden on healthcare systems.

Recent developments in the global infusion devices market include technology launches by Mackenzie Health and Medtronic, as well as product launches by Mindray and Fresenius Kabi. These advancements aim to improve patient safety, treatment accuracy, and overall healthcare outcomes. The market is witnessing an upsurge in product approvals and strategic collaborations.

Infusion devices are crucial for delivering fluids, medications, and nutrients directly into a patient’s body, providing precise control over treatment administration. The market comprises a wide range of products and accessories that are expected to exhibit strength during the forecast period. Overall, the market is driven by technological advancements, increasing healthcare demands, and a focus on improving patient outcomes.



Read more at GlobeNewswire: Infusion Devices Market to Reach US$ 23.08 Billion by 2031,